Immatics and Bristol Myers Squibb Enter Strategic Collaboration to Develop Off-the-shelf Allogeneic γδ-based TCR-T/ CAR-T Programs
Bristol Myers Squibb – Research collaboration
Immatics and Bristol Myers Squibb Enter Strategic Collaboration to Develop Off-the-shelf Allogeneic γδ-based TCR-T/ CAR-T Programs